subcutaneous drug delivery

Illustration connected puzzle pieces with the acronym MA
Favicon Fierce Pharma

Halozyme catches M&A wave to snap up Surf Bio

With IP protections extending into the mid-2040s, both Elektrofi & Surf could provide long-term, durable royalty revenue streams, Halozyme's CEO said.
Angus Liu Jan 28, 2026 2:06pm
Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am
puzzle pieces merger and acquisition business concept
Favicon Fierce Pharma

Halozyme buys Elektrofi for up to $900M

Oct 1, 2025 2:36pm
pivot change turnaround direction walk away

Lundbeck ends subcutaneous migraine cohort after futility review

Apr 1, 2025 5:00am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Glenmark bags subcutaneous checkpoint inhibitor rights

Jan 25, 2024 9:30am
Photo of a sunset over the horizon on a body of water

Viridian looks to beat Horizon's Tepezza in thyroid eye disease

Jul 10, 2023 4:01pm